Use of automation, dynamic image analysis, and process analytical technologies to enable data rich particle engineering efforts at the Drug Substance / Drug Product interface: A case study using Lovastatin

By Dr. Jeremy M. Merritt, Ph.D. Senior director and Group leader, Eli Lilly & Co. Automation plays a vital role in reducing development time in the pharmaceutical industry, both...

Dr. Jeremy M. Merritt, Eli Lilly & Co.

Jeremy M. Merritt (merrittje@lilly.com) is currently a Senior director and group leader at Eli Lilly and Co. in the synthetic molecule design and development organization (SMDD).  He joined Lilly...

Crystallization as a Purification Process: Visualizing Impurity Retention and its Effects on Crystal Properties

By Dr. Gerard Capellades, Assistant Professor, Rowan University   Industrial crystallization is heavily used as a purification step and to isolate valuable products with the desired solid-state properties. Consequently,...

Prof. Gerard Capellades, Rowan University

Gerard Capellades is an Assistant Professor at Rowan University’s Department of Chemical Engineering. He has worked on crystallization as his primary research field for the past 12 years, always...

Dr. Zheqiong (Sherry) Wu

Mr. Hanming Tu

Mr. David Kwajewski

Mrs. Xiaoyi Ding

Gautam Chauhan, Cipla USA

Gautam Chauhan is a senior scientist at Cipla Ltd. dedicated to provide accessible and affordable healthcare worldwide. With a profound background in pharmaceutical research and development, he has lead...

César A. Urbina, Ph.D.

César has a Ph.D. in Green Chemistry and Catalysis from the University of St Andrews and R&D experience in multiple research universities around the globe. He co-leads business development.